Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBF.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.15.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCBEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XCBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.8.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XSEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.519EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.519EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.514EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.514EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
GT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.87EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAPEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.68EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BR.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.51EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used